ArticleCancer control : journal of the Moffitt Cancer Center
Clinical Significance of SOX2 Promoter Methylation in Breast Cancer Prognosis.
Farhan Maqbool, Alfar Ahamed, Summaya Anwar, Muqadas Fatima, Shane Zahra, Erum Najeeb, Muhammad Saeed
Abstract read
In one paragraphArticle in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Farhan MaqboolCancer Genetics and Epigenetics Laboratory, Department of Biosciences, COMSATS University Islamabad (CUI), Islamabad, Pakistan.
Alfar AhamedCancer Genetics and Epigenetics Laboratory, Department of Biosciences, COMSATS University Islamabad (CUI), Islamabad, Pakistan.
Summaya AnwarCancer Genetics and Epigenetics Laboratory, Department of Biosciences, COMSATS University Islamabad (CUI), Islamabad, Pakistan.ORCID 0000-0002-9371-7902 Muqadas FatimaCancer Genetics and Epigenetics Laboratory, Department of Biosciences, COMSATS University Islamabad (CUI), Islamabad, Pakistan.
Shane ZahraCancer Genetics and Epigenetics Laboratory, Department of Biosciences, COMSATS University Islamabad (CUI), Islamabad, Pakistan.
Erum NajeebDepartment of Oncology, Pakistan Institute of Medical Sciences (PIMS), Islamabad, Pakistan.
Muhammad SaeedCancer Genetics and Epigenetics Laboratory, Department of Biosciences, COMSATS University Islamabad (CUI), Islamabad, Pakistan.ORCID 0000-0002-5998-787X Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Indexed as
Breast NeoplasmsDNA MethylationSOXB1 Transcription FactorsBiomarkers, TumorCross-Sectional StudiesDioxygenasesDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3BFemaleGene Expression Regulation, NeoplasticHumansMicroRNAsMiddle AgedNeoplastic Stem CellsPrognosisPromoter Regions, GeneticBiomarkers, TumorDioxygenasesDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3BMicroRNAsMIRN200 microRNA, humanSOX2 protein, humanSOXB1 Transcription FactorsTET3 protein, humanTransforming Growth Factor beta1breast cancer stem cells (BCSC)DNMT3bepigenetic biomarkersmiR200bprognosisSOX2 methylation
Identifiers
PMID42555815
PMCPMC13443240
What Socratic holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390